WALTHAM, Mass--()--Village Fertility Pharmacy, a specialty pharmacy focused exclusively on infertility treatments, today announced it has resumed compounding of certain sterile medications.
“The decision by DPH confirms our commitment to the highest standards of quality and safety as we deliver vital prescription medication to our patients”
The recent authorization from the Massachusetts Department of Public Health (DPH) followed Village’s voluntary product recall after particulate was found in vials of progesterone. Independent testing confirmed that sterility, potency, endotoxin, and fungal levels were all within acceptable limits. Further testing later determined the particulate was rubber stopper material.
On July 26, 2013, the Massachusetts Board of Registration in Pharmacy conducted an inspection of Village’s compounding facilities and determined that the operation of the facility is compliant with USP Chapter 797, the standard for sterile compounding issued by the U.S. Pharmacopeial Convention.
“The decision by DPH confirms our commitment to the highest standards of quality and safety as we deliver vital prescription medication to our patients,” said Stuart Levine, R.Ph., owner of Village Fertility Pharmacy. “We are pleased to move forward after taking a most cautious and prudent course with the voluntary recall and working cooperatively on this matter with all government agencies.”
About Village Fertility Pharmacy
Headquartered in Waltham, Village Fertility Pharmacy is a pharmacist-owned and operated specialty fertility pharmacy that is dedicated to providing exceptional service and educational resources to fertility patients and clinics nationwide.
No comments:
Post a Comment